<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250041</url>
  </required_header>
  <id_info>
    <org_study_id>10-153-SDR</org_study_id>
    <nct_id>NCT01250041</nct_id>
  </id_info>
  <brief_title>Continuous Saphenous Block Versus Continuous Femoral Block for Total Knee Arthroplasty</brief_title>
  <official_title>Continuous Saphenous Block Vs. Continuous Femoral Block for Total Knee Arthroplasty: Prospective, Randomized, Double Blind Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strength of the Quadriceps Muscle is key to recover from Total Knee Arthroplasty. In this
      study we compare two techniques for pain control after total knee arthroplasty in terms of
      preserving the motor function (the strength of the quadriceps muscles of the thigh) which
      will facilitate the rehabilitation and accelerate the hospital discharge. We will use
      ultrasound guided technique to block either the femoral nerve in the control group or the
      saphenous nerve in the experimental group. The primary outcome is the functional capacity and
      the impact of each block on the ability to walk by measuring the distance patients are able
      to walk in two minutes in post operative day one in the two groups. The secondary outcome is
      the morphine consumption in the two groups.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to assess the functional capacity and the impact of each block on the ability to walk by measuring the distance (the 2 minute walk test) in post op day one in the two groups.</measure>
    <time_frame>post op day one</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the morphine consumption in the two groups.</measure>
    <time_frame>post op day one</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Total Knee Arthroplasty Secondary to Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>femoral block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>saphenous block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous femoral nerve block</intervention_name>
    <description>ultrasound guided femoral nerve catheter insertion.</description>
    <arm_group_label>femoral block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous saphenous nerve block</intervention_name>
    <description>ultrasound guided saphenous nerve catheter insertion</description>
    <arm_group_label>saphenous block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Subject age over 18 years coming for total knee arthroplasty secondary to osteoarthritis

        Exclusion Criteria:

          -  ASA 4-5

          -  Abnormal liver enzymes, hepatic failure, renal failure and cardiac failure if they
             become contraindication for the use of regional anesthesia

          -  Contraindications for spinal anesthesia

          -  Morbid obesity

          -  Organ transplant

          -  Neuropathic pain

          -  History of stroke or major neurological deficit

          -  Sensory and motor disorders in the operated limb

          -  Previous drug dependency

          -  Chronic use of opioids

          -  Allergy to local anesthetics

          -  Inability to comprehend pain assessment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JF Asenjo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JF Asengo, MD</last_name>
    <phone>(514) 934-1934</phone>
    <phone_ext>43261</phone_ext>
    <email>jfasenjog@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>JF Asenjo, MD</last_name>
      <phone>514) 934-1934</phone>
      <phone_ext>43261</phone_ext>
      <email>jfasenjog@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>JF Asenjo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <last_update_submitted>November 29, 2010</last_update_submitted>
  <last_update_submitted_qc>November 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>JF Asenjo</name_title>
    <organization>MUHC</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

